What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary

被引：0

作者：

Iolascon, Giovanni ^{[1
]}

机构：

[1] Univ Campania Luigi Vanvitelli, Naples, Italy

来源：

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2021年 / 24卷 / 10期

关键词：

belimumab; Cochrane Review summary; systemic lupus erythematosus;

D O I：

10.1111/1756-185X.14214

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1331 / 1333

页数：3

共 50 条

[1] Belimumab for Systemic Lupus Erythematosus: A Cochrane Systematic Review and MetaAnalysis
Singh, Jasvinder A.
Shah, Nipam
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[2] What are the potential benefits and harms of exercise programs for patients with ankylosing spondylitis? A Cochrane review summary with commentary
Benlidayi, Ilke Coskun
[J]. TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2020, 66 (01): : 84 - 87
[3] WHAT ARE THE BENEFITS AND HARMS OF PHYSICAL ACTIVITY ON IRRITABLE BOWEL SYNDROME?- A COCHRANE REVIEW SUMMARY WITH COMMENTARY
Liguori, Sara
[J]. JOURNAL OF REHABILITATION MEDICINE, 2023, 55
[4] Which interventions are effective for cutaneous disease in systemic lupus erythematosus? A Cochrane Review summary with commentary
de Sire, Alessandro
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1540 - 1542
[5] Belimumab: A Review in Systemic Lupus Erythematosus
Blair, Hannah A.
Duggan, Sean T.
[J]. DRUGS, 2018, 78 (03) : 355 - 366
[6] Belimumab: A Review in Systemic Lupus Erythematosus
Hannah A. Blair
Sean T. Duggan
[J]. Drugs, 2018, 78 : 355 - 366
[7] Interventions for Cutaneous Disease in Systemic Lupus Erythematosus Summary of a Cochrane Review
Sprow, Grant
Afarideh, Mohsen
Werth, Victoria P.
[J]. JAMA DERMATOLOGY, 2022, 158 (02) : 200 - 201
[8] What Are the Benefits and Harms of Nonsteroidal Anti-Inflammatory Drugs for Trigger Finger? A Cochrane Review Summary With Commentary
Afridi, Ayesha
Rathore, Farooq Azam
[J]. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2022, 101 (06) : 581 - 583
[9] Belimumab: Review of Use in Systemic Lupus Erythematosus
Boyce, Eric G.
Fusco, Bryan E.
[J]. CLINICAL THERAPEUTICS, 2012, 34 (05) : 1006 - 1022
[10] Belimumab in systemic lupus erythematosus: a perspective review
Hui-Yuen, Joyce S.
Li, Xiao Q.
Askanase, Anca D.
[J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2015, 7 (04) : 115 - 121

← 1 2 3 4 5 →